Table 1.
Patients’ characteristics
| (n = 30) | Value |
|---|---|
| Male gender | 21 (70%) |
| Mean age ± SD (y) | 65 ± 7.1 |
| CAD risk factors (n) | |
| BMI >30 | 8 (27%) |
| Diabetes mellitus | 10 (33%) |
| Hypertension | 20 (67%) |
| Dyslipidaemia | 18 (60%) |
| Smoking history | 17 (57%) |
| Family history | 7 (23%) |
| >3 CAD risk factors | 15 (50%) |
| Chest pain | 15 (50%) |
| Medical therapy | |
| Clopidogrel | 4 (13%) |
| Aspirin | 30 (100%) |
| β-blockers | 18 (60%) |
| ACE inhibitors or AT-II antagonist | 17 (57%) |
| Calcium channel blockers | 6 (20%) |
| Coumadine | 2 (7%) |
| Statins | 25 (83%) |
| Oral antidiabetic | 12 (40%) |
| Long acting nitrates | 6 (20%) |
| Diuretics | 3 (10%) |
| Insulin | 3 (10%) |